RecruitingPhase 2NCT01773278
Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)
Studying Smith-Lemli-Opitz syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Colorado, Denver
- Principal Investigator
- Ellen R Elias, MD, MDUniversity of Colorado, Denver
- Intervention
- Antioxidants(drug)
- Enrollment
- 100 enrolled
- Eligibility
- 65 years · All sexes
- Timeline
- 2008 – 2025
Study locations (1)
- Children's Hospital Colorado, Aurora, Colorado, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01773278 on ClinicalTrials.gov